ROCKWELL MEDICAL, INC. Available-for-sale Securities, Amortized Cost Basis
ROCKWELL MEDICAL, INC. (RMTI) had Available-for-sale Securities, Amortized Cost Basis of $52.71 million as of 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-03-15
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $52.71M.
- 2016-12-31: Available-for-sale Securities, Amortized Cost Basis $24.52M.
- 2015-12-31: Available-for-sale Securities, Amortized Cost Basis $1.53M; Available-for-sale Securities, Amortized Cost Basis as first filed $1.53M.
- 2014-12-31: Available-for-sale Securities, Amortized Cost Basis $4.98M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2017-12-31 | $52.71M 10-K · filed 2018-03-15 | |
| 2016-12-31 | $24.52M 10-K · filed 2018-03-15 | |
| 2015-12-31 | $1.53M 10-K · filed 2017-03-15 | $1.53M 10-K · filed 2016-02-29 |
| 2014-12-31 | $4.98M 10-K · filed 2016-02-29 | |
| 2012-12-31 | $14.10M 10-K · filed 2014-03-07 | |
| 2011-12-31 | $2.08M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |